TransMedics Group (TMDX) PT Raised to $79 at Canaccord Genuity Ahead of a Transformational Year
Tweet Send to a Friend
Canaccord Genuity analyst Jason Mills raised the price target on TransMedics Group (NASDAQ: TMDX) to $79.00 (from $46.00) after taking ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
